OBJECTIVE: We aimed to determine the diagnostic values of some clinical and ultrasonographic features for predicting ovarian malignancies in patients with normal serum CA-125 levels. STUDY DESIGN: All of the 84 patients who were diagnosed with ovarian malignancy and 168 patients with benign adnexal mass had normal CA-125 levels, and recruited as study and control groups, respectively. Individual characteristics, ultrasonographic features, and risk of malignancy index (RMI) values of the groups were compared retrospectively. RESULTS: The ages, mean postmenopausal period of the postmenopausal women in the malignant group were significantly higher than the benign group. Nulliparity rates were similar between the two groups. The number of postm...
Purpose: Serum CA-125 level is commonly used as indicator for ovarian cancer recurrence. However, it...
Contains fulltext : 81907.pdf (publisher's version ) (Closed access)We studied pre...
OBJECTIVES: To determine whether CA 125 measurement is superior to ultrasound imaging performed by a...
CONTEXT: There is no adequate preoperative method for differentiating between benign and malignant p...
Objectives To evaluate the capacity to predict malignancy in women with adnexal tumors using CA 125 ...
To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to distingu...
Purpose To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to ...
To evaluate the capacity to predict malignancy in women with adnexal tumors using CA 125 measurement...
BACKGROUND: The CA-125 tumor marker has limitations when used to distinguish between benign and mali...
BACKGROUND: The CA-125 tumor marker has limitations when used to distinguish between benign and mali...
Objective: We sought to determine the validity of cancer antigen 125 (CA-125) and the risk of malign...
Objective: To verify the basic preoperative evaluation in the discrimination between benign and mali...
risk of malignancy index (RMI) — in differentiating between benign and borderline or malignant ovari...
OBJECTIVE: To evaluate the ability of two malignancy risk indices (RMI 1 and RMI 2) incorporating m...
Background: Preoperative discrimination between benign and malignant ovarian neoplasm is necessary t...
Purpose: Serum CA-125 level is commonly used as indicator for ovarian cancer recurrence. However, it...
Contains fulltext : 81907.pdf (publisher's version ) (Closed access)We studied pre...
OBJECTIVES: To determine whether CA 125 measurement is superior to ultrasound imaging performed by a...
CONTEXT: There is no adequate preoperative method for differentiating between benign and malignant p...
Objectives To evaluate the capacity to predict malignancy in women with adnexal tumors using CA 125 ...
To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to distingu...
Purpose To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to ...
To evaluate the capacity to predict malignancy in women with adnexal tumors using CA 125 measurement...
BACKGROUND: The CA-125 tumor marker has limitations when used to distinguish between benign and mali...
BACKGROUND: The CA-125 tumor marker has limitations when used to distinguish between benign and mali...
Objective: We sought to determine the validity of cancer antigen 125 (CA-125) and the risk of malign...
Objective: To verify the basic preoperative evaluation in the discrimination between benign and mali...
risk of malignancy index (RMI) — in differentiating between benign and borderline or malignant ovari...
OBJECTIVE: To evaluate the ability of two malignancy risk indices (RMI 1 and RMI 2) incorporating m...
Background: Preoperative discrimination between benign and malignant ovarian neoplasm is necessary t...
Purpose: Serum CA-125 level is commonly used as indicator for ovarian cancer recurrence. However, it...
Contains fulltext : 81907.pdf (publisher's version ) (Closed access)We studied pre...
OBJECTIVES: To determine whether CA 125 measurement is superior to ultrasound imaging performed by a...